Seoul, South Korea

Soo Youn Jun

This inventor holds 46 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Antibacterial Proteins. Top assignees: Intron Biotechnology, Inc., Intron Blotechnology, Inc.. Active years: 2015-2025.

USPTO Granted Patents = 46 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Seoul, KP (2015)
  • Seoul, KR (2016 - 2023)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antibacterial Protein
Bacteriophage
Clostridioides Difficile
Gram-Negative Infections
Pathogenic Proliferation
Vibrio Parahaemolyticus
Inhibition Methods
Lytic Activity
Staphylococcal Infections
Heme Iron Preparation
46 patents (USPTO):Explore Patents

Title: Innovations of Soo Youn Jun in Bacteriophage Research

Introduction

Soo Youn Jun, an accomplished inventor based in Seoul, South Korea, holds an impressive portfolio of 41 patents. His work focuses primarily on bacteriophages and their potential to inhibit bacterial growth, contributing significantly to the field of microbiology and therapeutic innovations.

Latest Patents

Among his recent inventions are two groundbreaking patents: the bacteriophage STP-2 and the bacteriophage Aer-HYP-3. The bacteriophage STP-2 (Accession number: KCTC 12853BP) is notable for its ability to destroy specific bacteria, with a genome represented by SEQ ID NO:1. This invention also encompasses a method for preventing and treating diseases caused by bacteria using STP-2 as an active ingredient. Similarly, the Myoviridae bacteriophage Aer-HYP-3 (Accession number: KCTC 13479BP) has been isolated from nature and demonstrated to effectively kill bacteria, also represented by a genome indicated as SEQ ID NO:1. This patent includes a method for disease prevention and treatment, utilizing a composition containing Aer-HYP-3.

Career Highlights

Soo Youn Jun has contributed his expertise to notable companies, such as Intron Biotechnology and Intron Biotechnology, Inc., playing a vital role in advancing bacteriophage research. His dedication to innovation in this field is reflected in his extensive patent portfolio, which showcases his commitment to developing effective solutions for bacterial infections.

Collaborations

Throughout his career, Soo Youn Jun has collaborated with several professionals, including Seong Jun Yoon and Sang Hyeon Kang. These partnerships have facilitated knowledge exchange and further enhanced the quality and impact of his inventions.

Conclusion

Soo Youn Jun's contributions to the field of bacteriophage research stand as a testament to his innovative spirit and dedication to improving public health. With a track record of 41 patents, his work continues to pave the way for novel therapeutic solutions, highlighting the importance of innovation in the fight against bacterial diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…